| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.08 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |